Transplant Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2014 – 2022, states that the global transplant diagnostics market was $524.7 million and is expected to reach $ 1,031 million, with a CAGR of 10% from 2019 to 2025. The serological assay technology is the most preferred, which accounted for about half of the market share globally, in 2018. The reagents & consumables segment is projected to remain dominant throughout the forecast period. North America held the leading market position in 2015, and is expected to maintain this trend.
Download Sample Report with Detail Covid-19 Impact Analysis@ https://www.alliedmarketresearch.com/request-sample/1135
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
The major players have adopted product approval & launch as their key strategy to cater to the volatile industry needs and merger & acquisition to strengthen their brand value, product portfolio, and market position. Development of novel products incorporated with innovative technology supplemented with aggressive acquisition activity are the instrumental strategies adopted by leading players. The key players profiled in this report include Immucor, Inc. (TGI Capital), Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc. F. Hoffmann-la Roche AG, Illumina Inc., Abbott Laboratories, Sigma-Aldrich Corporation, Qiagen N. V., Olerup SSP AB (Allenex), and Diasorin S.P.A. Thermo Fisher occupies a major share in the transplant diagnostics market, owing to its novel product portfolio and diverse geographical presence.
The reagents & consumables segment accounted for the maximum revenue generation in 2015, owing to the increased number of diagnostics procedures pre and post organ transplantation. The instruments & equipment segment is projected to grow at a CAGR of 9.1% and reach $76.3 million by 2022. Both the technologies, namely non molecular assay and molecular assay hold significant position in the global transplant diagnostics market. However, molecular assay technology segment is projected to grow at the highest CAGR of 12.3%, due to highly accurate results provided by the modern molecular assay technology.
Used for performing transplant diagnostics procedures are equipped with highly sophisticated technology such as next-generation sequencing, which is current market trend,” she further added.
With rise in number of kidney transplants, the segment is set to report a high revenue in the future, with a CAGR of 9.8%, owing to increased incidence of renal failure worldwide. Liver and heart transplants are estimated to report a strong growth rate during the forecast duration, due to increased awareness for organ donations and increase in incidence of liver and heart failure.
Inquiry for Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/1135
North America accounted for a major market share, with maximum revenue contribution from the U.S., due to large number of transplant procedures of kidney, liver, lung, heart, and pancreas. Adoption of latest technology and increase in awareness regrading organ transplantation in the U.S. have boosted the North American transplant diagnostics market. The Asia-Pacific region offers lucrative opportunities for transplant diagnostics market players to expand their market presence. This region has the highest geriatric population, and the scenario is estimated to continue; further felling market growth for transplant diagnostics.
Similar Reports with COVID-19 Impact:
STD Reimbursement Scenario Market – Global Opportunity Analysis and Industry Forecasts, 2019 – 2025
Medical Imaging Reagents Market – Global Opportunity Analysis and Industry Forecasts, 2019 – 2025
Automated Radiosynthesis Modules Market – Global Opportunity Analysis and Industry Forecasts, 2019 – 2025
3D Imaging Market – Global Opportunity Analysis and Industry Forecasts, 2019 – 2025
Disposable Medical Sensors Market – Global Opportunity Analysis and Industry Forecasts, 2019 – 2025
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.